Cardiovascular benefits of paricalcitol in chronic kidney disease

被引：0
|
作者：
Jessica K. Edwards
机构：
来源：
Nature Reviews Nephrology | 2014年 / 10卷 / 12期
关键词：
D O I：
10.1038/nrneph.2014.200
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：675 / 675
相关论文
共 50 条
  • [21] The Benefits of Fiber in Chronic Kidney Disease
    Lochmann, Heather
    JOURNAL OF RENAL NUTRITION, 2022, 32 (06) : E1 - E4
  • [22] Potential benefits of hormone replacement therapy on cardiovascular and kidney outcomes in postmenopausal women with chronic kidney disease
    Cho, Semin
    Kim, Minsang
    Jung, Sehyun
    Cho, Jeong Min
    Kim, Seong Geun
    Park, Sehoon
    Lee, Soojin
    Kang, Eunjeong
    Kim, Yaerim
    Joo, Kwon Wook
    Han, Kyungdo
    Kim, Dong Ki
    Huh, Hyuk
    JOURNAL OF NEPHROLOGY, 2024, : 491 - 501
  • [23] Potential benefits of renal diets on cardiovascular risk factors in chronic kidney disease patients
    Cupisti, Adamasco
    Aparicio, Michel
    Barsotti, Giuliano
    RENAL FAILURE, 2007, 29 (05) : 529 - 534
  • [24] Benefits of Semaglutide on Chronic Kidney Disease Outcomes by Cardiovascular Status or Risk in the FLOW trial
    Tuttle, Katherine
    Bakris, George
    Bang, Casper
    Bax, Willem
    Belmar, Nicolas
    Brown, Paul
    Cherney, David
    Chernin, Gil
    Lim, Soo Kun
    Mann, Johannes
    Perkovic, Vlado
    Pratley, Richard
    Ridker, Paul
    Rossing, Peter
    Schmieder, Roland
    Shamkhalova, Minara S.
    Sreenivasamurthy, L.
    Mahaffey, Kenneth
    CIRCULATION, 2024, 150 (25) : E746 - E746
  • [25] Microalbuminuria: another use for paricalcitol? Our experience in advanced chronic kidney disease
    Blanco-Garcia, Raquel
    Bravo-Lopez, Juan J.
    Moreiras-Plaza, Mercedes
    Najera-de la Garza, Walfred
    Cossio-Annibar, Cynthia
    Beato-Coo, Laura
    Rodriguez-Goyanes, Gloria
    NEFROLOGIA, 2012, 32 (03): : 401 - 402
  • [26] Oral paricalcitol: expanding therapeutic options for pediatric chronic kidney disease patients
    Michael Freundlich
    Carolyn L. Abitbol
    Pediatric Nephrology, 2017, 32 : 1103 - 1108
  • [27] Efficacy and Safety of Paricalcitol Therapy for Chronic Kidney Disease: A Meta-Analysis
    Cheng, Jun
    Zhang, Wen
    Zhang, Xiaohui
    Li, Xiayu
    Chen, Jianghua
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (03): : 391 - 400
  • [28] Proteinuria and Albuminuria During and After Paricalcitol Treatment in Chronic Kidney Disease Patients
    Ekart, Robert
    Bevc, Sebastjan
    Hojs, Radovan
    Hojs, Nina
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (06): : 761 - 768
  • [29] Cardiovascular disease and the kidney - Tracking a killer in chronic kidney disease
    Levin, A
    Stevens, L
    McCullough, PA
    POSTGRADUATE MEDICINE, 2002, 111 (04) : 53 - 60
  • [30] Cardiovascular disease in children with chronic kidney disease
    Kouri, Anne M.
    Rheault, Michelle N.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2021, 30 (02): : 231 - 236
12345